EBR Systems enrolled the first patients in the WiSE-UP study evaluating its WiSE cardiac resynchronization therapy (CRT) ...

Left-sided heart failure occurs when the left ventricle of the heart is unable to adequately pump blood to the rest of the body. This is the most prevalent type of heart failure and it becomes ...

New trial shows stem cells prevent heart failure after heart attack, offering hope for cardiac recovery. Keep reading.

Children with congenital complete atrioventricular block often require lifelong pacemaker therapy. Although such therapy restores a normal heart rate, it also results in dyssynchronous left ...

EBR Systems, Inc., developer of the world's only wireless cardiac pacing system for heart failure, today announced the first ...

Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure. The ...

The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need ...

Wave's pivotal trial, Dr. William Abraham is working on another heart failure trial as the new CMO at Cardiac Dimensions.

Peripartum cardiomyopathy (PPCM) is a rare but life-threatening condition that can affect women with previously healthy ...

CHICAGO, IL — AUGMENT HF, a phase 2 trial of 78 patients with advanced heart failure, showed that an injection of the novel hydrogel Algisyl-LVR hydrogel (LoneStar Heart, Dallas, TX) into their left ...

Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according ...